FCX vs HIVE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 12, 2026
FCX
38.7
AI Score
VS
HIVE Wins
HIVE
48.3
AI Score
Investment Advisor Scores
HIVE
48score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | FCX | HIVE | Winner |
|---|---|---|---|
| Revenue | 13.26B | 79.12M | FCX |
| Net Income | 1.86B | -142.91M | FCX |
| Net Margin | 14.1% | -180.6% | FCX |
| ROE | 9.3% | -33.8% | FCX |
| ROA | 3.1% | -15.5% | FCX |
| Total Assets | 59.73B | 924.64M | FCX |
| Cash | 4.08B | 208.04M | FCX |
| Current Ratio | 2.07 | 1.96 | FCX |
Relative Price Performance (Last 90 Days)
FCX 1M: +2.7%
· 3M: +7.1%
HIVE 1M: +10.6%
· 3M: -20.1%
Current Technical Phase
FCX
NeutralHold
Mixed signals - no dominant trend phase, RSI 48
HIVE
NeutralHold
Mixed signals - no dominant trend phase, RSI 52
Fundamentals Snapshot
| Metric | FCX | HIVE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 17.2 | -5.9 |
| Trailing P/E | 34.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.7% |
| Gross Margin | 0.4% | 0.4% |
| Operating Margin | 0.3% | -0.6% |
| EPS | 2.04 | -1.33 |
| Dividend Yield | 0.01% | — |
Frequently Asked Questions
Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.